Effect of Propofol on the Production of Inflammatory Cytokines by Human Polarized Macrophages. 2019

Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Macrophages are key immune system cells involved in inflammatory processes. Classically activated (M1) macrophages are characterized by strong antimicrobicidal properties, whereas alternatively activated (M2) macrophages are involved in wound healing. Severe inflammation can induce postoperative complications during the perioperative period. Invasive surgical procedures induce polarization to M1 macrophages and associated complications. As perioperative management, it is an important strategy to regulate polarization and functions of macrophages during inflammatory processes. Although propofol has been found to exhibit anti-inflammatory activities in monocytes and macrophages, it is unclear whether propofol regulates the functions of M1 and M2 macrophages during inflammatory processes. This study therefore investigated the effects of propofol on human macrophage polarization. During M1 polarization, propofol suppressed the production of IL-6 and IL-1β but did not affect TNF-α production. In contrast, propofol did not affect the gene expression of M2 markers, such as IL-10, TGF-β, and CD206, during M2 polarization. Propofol was similar to the GABAA agonist muscimol in inducing nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) and inhibiting IL-6 and IL-1β, but not TNF-α, production. Knockdown of Nrf2 using siRNA significantly reduced the effect of propofol on IL-6 and IL-1β production. These results suggest that propofol prevents inflammatory responses during polarization of human M1 macrophages by suppressing the expression of IL-6 and IL-1β through the GABAA receptor and the Nrf2-mediated signal transduction pathway.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009118 Muscimol A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies. Agarin,Pantherine
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090323 Mannose Receptor A member of a family of endocytic receptors. Highly expressed on human macrophages, involved in regulating endocytosis, phagocytosis, and immune responses. CD206 Antigen,Cluster of Differentiation 206,MRC1 Protein,Mannose Receptors,Mannose-Fucose Receptor,Mannosyl-Fucosyl Receptor,Receptor, Mannose,206 Cluster, Differentiation,Antigen, CD206,Differentiation 206 Cluster,Mannose Fucose Receptor,Protein, MRC1,Receptor, Mannose-Fucose
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015742 Propofol An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS. Disoprofol,2,6-Bis(1-methylethyl)phenol,2,6-Diisopropylphenol,Aquafol,Diprivan,Disoprivan,Fresofol,ICI-35,868,ICI-35868,Ivofol,Propofol Abbott,Propofol Fresenius,Propofol MCT,Propofol Rovi,Propofol-Lipuro,Recofol,2,6 Diisopropylphenol,ICI 35,868,ICI 35868,ICI35,868,ICI35868
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
September 1988, Science (New York, N.Y.),
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
May 1998, Respiratory medicine,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
July 2009, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
September 2011, Journal of ethnopharmacology,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
September 2000, Shock (Augusta, Ga.),
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
November 2002, The Israel Medical Association journal : IMAJ,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
September 2018, The Science of the total environment,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
March 1999, Toxicology letters,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
January 2010, Journal of innate immunity,
Tsukasa Kochiyama, and Xiaojia Li, and Hitoshi Nakayama, and Madoka Kage, and Yui Yamane, and Kenji Takamori, and Kazuhisa Iwabuchi, and Eiichi Inada
February 1998, Infection and immunity,
Copied contents to your clipboard!